Liraglutide is a peptide that has gained significant attention in scientific research due to its structural similarity to ...

Metabolic-associated fatty liver disease (MAFLD) is a new disease definition, and this nomenclature MAFLD was proposed to renovate its former name, non-alcoholic fatty liver disease (NAFLD).

1 Department of Anatomy, Faculty of Medicine, University of Tabuk, Tabuk, Saudi Arabia 2 Department of Internal Medicine, Faculty of Medicine, University of Tabuk, Tabuk, Saudi Arabia Introduction: ...

The following is a summary of “Optimizing SGLT2 inhibitor and GLP-1 RA prescribing in high-risk patients with diabetes: a ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

Weight loss is a key effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), but these drugs may also provide liver ...

GLP-1 receptor agonists are peptide-based drugs used for managing diabetes and for weight loss, but these treatments have had shortages recently. Now, through a process called in vivo antibody ...

The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...